Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 6132
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 20 I
0167328 EU/1/09/583/052 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 28 I
0167329 EU/1/09/583/053 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 30 I
0167330 EU/1/09/583/054 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 56 I
0167331 EU/1/09/583/055 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 60 I
0167332 EU/1/09/583/056 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 90 I
0167333 EU/1/09/583/057 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 98 I
0167334 EU/1/09/583/058 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 100 I
0167335 EU/1/09/583/059 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 50X1 I
0167336 EU/1/09/583/060 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 7 II
0167337 EU/1/09/583/061 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 14 II
0167338 EU/1/09/583/062 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 15 II
0167339 EU/1/09/583/063 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 20 II
0167340 EU/1/09/583/064 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 28 II
0167341 EU/1/09/583/065 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 30 II
0167342 EU/1/09/583/066 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 56 II
0167343 EU/1/09/583/067 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 60 II
0167344 EU/1/09/583/068 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 90 II
0167345 EU/1/09/583/069 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 98 II
0167346 EU/1/09/583/070 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 100 II
0167347 EU/1/09/583/071 irbesartan.pdf irbesartan.pdf C09DA04 R

‹‹ ‹ 50 60 70 80 90 97 98 99 100 101 102 103 104 105 106 107 110 120 130 140 150 200 300 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 18. January 2022 at 00:08
Last update of price and payment data: 1. January 2022 at 00:11